Advanced Medical Solutions Grp PLC Director/PDMR Shareholding (0350K)

TIDMAMS

RNS Number : 0350K

Advanced Medical Solutions Grp PLC

05 April 2018

 
 
     5 April 2018 
 

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that it was notified on 29 March 2018 that on the same day, Penny Freer, who is a Director, had sold 13,888 Ordinary Shares of 5p held in her name at a price of 318.60p per Ordinary Share. On the same day, Penny Freer also purchased 13,888 Ordinary Shares of 5p through a self-invested personal pension ("SIPP") held in her name at a price of 318.80p per Ordinary Share.

The number of shares held by Penny Freer and the beneficial ownership of the shares remains unchanged. Both transactions are part of normalised tax planning.

The transactions are summarised below:

 
 Director    Number of      Price per     Number of           Price paid 
              Ordinary       Ordinary      Ordinary            per Ordinary 
              Shares sold    Share sold    Shares purchased    Share by 
              from Penny                   by SIPP             SIPP 
              Freer 
----------  -------------  ------------  ------------------  -------------- 
 Penny 
  Freer      13,888         318.60p       13,888              318.80p 
----------  -------------  ------------  ------------------  -------------- 
 

Advanced Medical Solutions Group plc also announces that it was notified on 4 April 2018 that on the same day, Chris Meredith, who is a Director and PDMR, had sold 10,500 Ordinary Shares of 5p held in the name of Platform Securities Nominees Limited ("Nominee") at a price of 310.20p per Ordinary Share.

On the same day, Chris Meredith purchased 2,568 Ordinary Shares of 5p through a self-invested personal pension ("SIPP") held in his name at a price of 310.50p per Ordinary Share. The Company was also informed that at the same time Individual Savings Accounts ("ISA's") held in the name of Chris Meredith's PCA's purchased 4,095 Ordinary Shares of 5p at a price of 310.50p per Ordinary Share and that Lifetime Individual Savings Accounts ("LISA's") held in the name of Chris Meredith's PCA's purchased 3,837 Ordinary Shares of 5p at a price of 310.50p per Ordinary Share.

The number of shares, and the beneficial ownership of the shares, held by Chris Meredith and his PCA's remains unchanged. These transactions are part of normalised tax planning.

The transactions are summarised below:

 
 Director     Number        Price       Number        Price       Number         Price       Number         Price 
              of Ordinary    per        of Ordinary    paid        of Ordinary    paid        of Ordinary    paid 
              Shares         Ordinary   Shares         per         Shares         per         Shares         per 
              sold           Share      purchased      Ordinary    purchased      Ordinary    purchased      Ordinary 
              from           sold       by SIPP        Share       by ISA's       Share       by LISA's      Share 
              Nominee                                  by                         by ISA's                   by LISA's 
                                                       SIPP 
-----------  ------------  ----------  ------------  ----------  -------------  ----------  -------------  ----------- 
 Chris 
  Meredith    2,568         310.20p     2,568         310.50p     -              -           -              - 
-----------  ------------  ----------  ------------  ----------  -------------  ----------  -------------  ----------- 
 Chris 
  Meredith    4,095         310.20p     -             -           4,095          310.50p     -              - 
-----------  ------------  ----------  ------------  ----------  -------------  ----------  -------------  ----------- 
 Chris 
  Meredith    3,837         310.20p     -             -           -              -           3,837          310.50p 
-----------  ------------  ----------  ------------  ----------  -------------  ----------  -------------  ----------- 
 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ---------------------------------------------------------------- 
 a)   Name: Penny Freer 
---  ---------------------------------------------------------------- 
 2.   Reason for the notification 
---  ---------------------------------------------------------------- 
 a)   Position/status: Director 
---  ---------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ---------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ---------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ---------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ---------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ---------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ---------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Sale of 13,888 Ordinary Shares of 5p held in the name 
                of Penny Freer 
 
 
           *    Purchase of 13,888 Ordinary Shares of 5p by a SIPP 
                held in the name of Penny Freer 
---  ---------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)                 Volume(s) 
       -----------------------  ---------- 
        Sale of shares from 
         Penny Freer holding 
         at 318.60p per share    13,888 
       -----------------------  ---------- 
        Purchase by SIPP at 
         318.80p per share       13,888 
       -----------------------  ---------- 
---  ---------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 13,888 
       Aggregated price: 318.60p 
---  ---------------------------------------------------------------- 
 e)   Date of the transaction: 29/03/2018 
---  ---------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ---------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ---------------------------------------------------------------------- 
 a)   Name: Chris Meredith 
---  ---------------------------------------------------------------------- 
 2.   Reason for the notification 
---  ---------------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  ---------------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ---------------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ---------------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ---------------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ---------------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ---------------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ---------------------------------------------------------------------- 
 b)             Nature of the transactions: 
                  *    Sale of 2,568 Ordinary Shares of 5p held in the name 
                       of the Nominee 
 
 
                  *    Purchase of 2,568 Ordinary Shares of 5p by a SIPP 
                       held in the name of Chris Meredith 
---  ---------------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)               Volume(s) 
       ---------------------  ---------- 
        Sale of shares from 
         Nominee holding at 
         310.20p per share     2,568 
       ---------------------  ---------- 
        Purchase by SIPP at 
         310.50p per share     2,568 
       ---------------------  ---------- 
---  ---------------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 2,568 
       Aggregated price: 310.20p 
---  ---------------------------------------------------------------------- 
 e)   Date of the transaction: 04/04/2018 
---  ---------------------------------------------------------------------- 

 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ---------------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ---------------------------------------------------------------------- 
 a)   Name: Chris Meredith 
---  ---------------------------------------------------------------------- 
 2.   Reason for the notification 
---  ---------------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  ---------------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ---------------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ---------------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ---------------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ---------------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ---------------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ---------------------------------------------------------------------- 
 b)             Nature of the transactions: 
                  *    Sale of 4,095 Ordinary Shares of 5p held in the name 
                       of the Nominee 
 
 
                  *    Purchase of 4,095 Ordinary Shares of 5p into ISA's 
                       held in the name of Chris Meredith's PCA's 
---  ---------------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)                 Volume(s) 
       -----------------------  ---------- 
        Sale of shares from 
         Nominee holding at 
         310.20p per share       4,095 
       -----------------------  ---------- 
        Purchase by ISA's 
         at 310.50p per share    4,095 
       -----------------------  ---------- 
---  ---------------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 4,095 
       Aggregated price: 310.20p 
---  ---------------------------------------------------------------------- 
 e)   Date of the transaction: 04/04/2018 
---  ---------------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ---------------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ----------------------------------------------------------------------- 
 a)   Name: Chris Meredith 
---  ----------------------------------------------------------------------- 
 2.   Reason for the notification 
---  ----------------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  ----------------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ----------------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ----------------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ----------------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ----------------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ----------------------------------------------------------------------- 
 b)             Nature of the transactions: 
                  *    Sale of 3,837 Ordinary Shares of 5p held in the name 
                       of the Nominee 
 
 
                  *    Purchase of 3,837 Ordinary Shares of 5p into a LISA's 
                       held in the name of Chris Meredith's PCA's 
---  ----------------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)                 Volume(s) 
       -----------------------  ---------- 
        Sale of shares from 
         Nominee holding at 
         310.20p per share       3,837 
       -----------------------  ---------- 
        Purchase by LISA's 
         at 310.50p per share    3,837 
       -----------------------  ---------- 
---  ----------------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 3,837 
       Aggregated price: 310.20p 
---  ----------------------------------------------------------------------- 
 e)   Date of the transaction: 04/04/2018 
---  ----------------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ----------------------------------------------------------------------- 
 

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                Tel: +44 (0) 
  plc                                             1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Chief Financial 
  Officer 
 
 Consilium Strategic Communications              Tel: +44 (0) 
                                                 20 3709 5700 
 Mary-Jane Elliott / Matthew Neal     [e-mail] 
  / Philippa Gardner 
 
 Investec Bank PLC (NOMAD & Broker)              Tel: +44 (0) 
                                                 20 7597 5970 
 Daniel Adams / Patrick Robb / 
  Gary Clarence 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. . For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBLGDSUSGBGIU

(END) Dow Jones Newswires

April 05, 2018 12:46 ET (16:46 GMT)